Top Stories

Published on Thursday, April 11, 2019

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

On April 3, 2019, Francis Collins, MD, PhD, director of the National Institutes of Health (NIH), Mikael Dolsten, MD, PhD, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer, joined in a discussion led by Susan Dentzer, visiting fellow at the Robert J. Margolis Center for Health Policy, Duke University, in Washington DC.

Photo: Francis Collins, MD, PhD, director of the NIH (left) and author Alejandro Hernandez, editorial manager of the Alpha-1 Foundation (right)

For 60 minutes, Collins, Dolsten, and Dentzer engaged in a conversation with the theme of: “Advancing the innovation ecosystem: working together for patients,” where they emphasized the need for continued collaboration between the private and public sectors, along with the patient community, in order to advance new and emerging technologies and innovative approaches for potentially life-saving treatments and new outcomes in medicine.

“We are currently living in remarkable times with amazing things happening in areas such as cancer immuno-therapy, gene therapy, and gene editing. The things that are happening right now, I had no idea they would even be possible just five or six years ago,” expressed Collins when asked about the current position “the ecosystem,” as they described the collaboration between the private and public sectors with small biotech companies; an ecosystem with symbiotic characteristics where all contributors play an important role in a tremendous team effort, in medical research.

Collins and Dolsten agreed on the importance of advocacy groups and organizations as well as the patient community, in being part of the process for better outcomes and the ability to bring new and potential treatments for various conditions to the clinic, including rare diseases, such as Alpha-1 Antitrypsin Deficiency (Alpha-1). 

“We need you, the patient community, you are the reason we have gotten this far,” said Collins.

“One of the most important resources needed for this ecosystem to strive is you, the patient. We need to line-up our resources and keep the ecosystem going, including the patient community. There is no one better to bring together what others (physicians) can do than patients: you inspire all of us,” expressed Dolsten.

The Alpha-1 Foundation applauds and supports these types of initiatives, in which patients become partners and are of vital importance for therapeutic development. 

The panel also mentioned that it is critical to spread awareness and education in the medical community, and being able to have early diagnosis and detection, while mentioning the Accelerating Medicines Partnership (AMP), a public-private partnership between the NIH, the U.S. Food and Drug Administration (FDA), multiple biopharmaceutical, and life science companies, as well as non-profit organizations to transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets for therapeutics.

The ultimate goal of AMP is to increase the number of new diagnostics and therapies for patients and reduce the time and cost of developing them.

“Patient participation is critical for AMP, especially to remind us what we are doing and why-and-who we are doing it for,” said Collins, who also mentioned the Foundation for the National Institutes of Health (FNIH) as being instrumental in bringing together funds and resources from both the private and public sectors, to work in mutual collaboration in research projects that will ultimately benefit the patient community.

The Alpha-1 Foundation applauds these types of initiatives that support research and bring innovative approaches to the table for the benefit of the patient community, as we are committed to finding a cure for Alpha-1 and improving the lives of Alphas, and those affected by the condition, worldwide.

For more information, please visit the Collaboration Ecosystem website and the AMP website.


Roadtrip encounter signals more know about Alpha-1

Friday, March 4, 2011
Pierre Villeneuve, a Florida resident, was diagnosed with Alpha-1 at the age of 39. Since then, Villeneuve and his wife Alex attend Alpha-1 support groups, conferences and education days, and do what they can to raise awareness about...

COPD patients who socialize live longer; study finds loneliness is as harmful as alcoholism and smoking

Thursday, July 29, 2010
Medical News Today A new study suggests that social interaction should be considered an important factor for extending lifespan, on a par with other health and lifestyle factors. In fact, low social interaction harms longevity as much as...

New US website on Disabilities and Health

Monday, July 26, 2010
The US Centers for Disease Control (CDC) has a new Disabilities and Health website. Some of the new features of the site include: Easy-to-read information on healthy living, secondary conditions, accessibility, and emergency...

"Bad Blood" film documents tragedy of tainted US blood supply in 1970s-1990s

Monday, July 26, 2010
New York, NY – The documentary film “Bad Blood: A Cautionary Tale,” will premiere Wednesday in New York City as the launch of a theatrical screening series co-hosted by a coalition of national gay rights and hemophilia advocacy...

Dr. Donohue suggests more Alpha-1 testing

Friday, July 23, 2010
A question today from the syndicated “Dr. Donahue” column DEAR DR. DONOHUE: My wife of 55 years died last year from the complications of an illness known as alpha-1 antitrypsin deficiency. In her late 40s, she would become unduly...

Patient advocacy group applauds new regulations to strengthen patients' right to appeal health insurance denials

Friday, July 23, 2010
Washington, DC—The National Health Council (NHC) today released a statement in support of today’s White House announcement of new federal regulations to strengthen patients’ rights to appeal health insurance denials. The Alpha-1...

Charles Leonard Geiger, MD, dies; father of well-known Alpha

Friday, July 16, 2010
GAINESVILLE, GA—Charles Leonard Geiger, MD, died Wednesday, July 14. A retired pathologist, he had formerly been an officer in the US Air Force Medical Service and professor of clinical pathology at Emory Medical School. He was the father...

Alpha-1 patient in Canada doing well after getting lung transplant despite infection with H1N1 (swine flu) virus

Wednesday, July 14, 2010
CBC News EDMONTON, Alberta—A 50-year-old Canadian with Alpha-1 Antitrypsin Deficiency underwent a successful double lung transplant last year in Edmonton even though he was infected with the H1N1 virus at the time of the surgery, doctors...

Iowa Alpha-1 education day August 28 features talks on importance of exercise, getting to positive, advocacy opportunities and More

Tuesday, July 6, 2010
DES MOINES, IA – Josh Stolpe, a Cardiopulmonary Specialist at Mercy Medical Center, will explain “The Importance of Exercise” at the Alpha-1 Education Day on August 28. Jeff Wilson, MD, Professor of Medicine at the University of...

FDA approves Kamada's IV drug Glassia as 4th US augmentation therapy for Alpha-1

Friday, July 2, 2010
Israeli biopharmaceutical company Kamada Inc. has been granted approval by the US Food and Drug Administration for Glassia, its intravenous augmentation therapy to treat emphysema due to Alpha-1 Antitrypsin Deficiency. Alpha-1 Antitrypsin...

Kathy Haduck receives Helen Chase Walsh Memorial Award

Thursday, June 17, 2010
AlphaNet Coordinator Kathy Haduck of Blandburg, PA, was honored with the Helen Chase Walsh Memorial Award at the recent annual education conference of the Alpha-1 Association in Orlando, FL. The award is presented each year by the Walsh family to...

Do you have the scoop on Alpha-1?

Thursday, June 17, 2010
Darin and Megan Chittick know exactly why it’s important to support Alpha-1 fundraisers. Their daughter, McKinley Chittick, who is now three years old, was diagnosed with Alpha-1 when she was just a month old. She developed severe jaundice...

Article Search

Enter keywords in text box and click Search button for results.